Publicaciones

  • Bleau AM, Freire J, Pajares MJ, Zudaire I, Anton I, Nistal-Villan E, Redrado M, Zandueta CN, Garmendia I, Ajona D, Blanco D, Pio R, Lecanda F, Calvo A, Montuenga LM. New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations. International Journal of Cancer 2014; 135: 2516-2527. IF: 5.007. Lugar: 34/203 Oncology. Primer cuartil.
    ABSTRACT CORTESÍA DE PUBMED

  • Larrayoz M, Pio R, Pajares MJ, Zudaire I, Ajona D, Casanovas O, Montuenga LM,Agorreta J. Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype. EMBO Mol Med 2014; 6: 539-550. IF (2012): 7.795. Lugar: 9/121 Medicine, Research & Experimental. Primer decil.
    ABSTRACT CORTESÍA DE PUBMED

  • Larzabal L, de Aberasturi AL, Redrado M, Rueda P, Rodriguez MJ, Bodegas ME, Montuenga LM, Calvo. TMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis. Br J Cancer 2014; 110: 764-774. IF (2012): 5.082; Lugar: 35/197 Oncology. 1er cuartil.
    ABSTRACT CORTESÍA DE PUBMED

  • Antón I, Molina E, Luis-Ravelo D, Zandueta C, Valencia K, Ormazabal C, Martínez-Canarias S, Pajares MJ, Agorreta J, Montuenga LM, Perurena N, Wistuba II, de las Rivas J, Segura V, Hermida J, Lecanda F. Activated Protein C and its Receptor Reduce Apoptosis and Promote Tumor Metastasis in Human Lung Adenocarcinoma. American J Resp & Crit Care Medicine 2012; 186: 96-105. IF: 11.080; Lugar: 1/48 Respiratory System. Primer decil. 
    ABSTRACT CORTESÍA DE PUBMED

  • Martinez-Velez N, Xipell E, Jauregu P, Zalacain M, Marrodan L, Zandueta C, Vera B, Urquiza L, Sierrasesú- maga L, San Julián M, Toledo G, Pueyo J, Gomez-Manzano C, Torre W, Lecanda F, Patiño-García A, Alonso MM. The oncolytic adenovirus Δ24-RGD in combination with cisplatin exerts a potent  anti-osteosarcoma activity. J Bone Miner Res 2014; 29: 2287-96. IF: 6.589. Lugar: 12/124 Endocrinology and Metabolism. Primer decil.
    ABSTRACT CORTESÍA DE PUBMED

  • Corrales L, Ajona D, Rafail S, Lasarte JJ, Riezu-Boj JI, Lambris JD, Rouzaut A, Pajares MJ, Montuenga LM, Pío R. Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression. Journal of Immunology 2012; 189: 4674-4683. IF: 5.520. Lugar: 24/137 Immunology. Primer cuartil. 
    ABSTRACT CORTESÍA DE PUBMED

  • Freire J, Ajona D, de Biurrun G, Agorreta J, Segura V, Guruzeaga E, Bleau AM, Pío R, Blanco D, Montuenga LM. Silica-induced chronic inflammation promotes lung carcinogenesis in the context of an immunosuppressive microenvironment. Neoplasia 2013; 15: 913-924. IF: 5.398. Lugar: 28/203 Oncology. Primer cuartil. 
    ABSTRACT CORTESÍA DE PUBMED

  • Maška M, Ulman V, Svoboda D, Matula P, Matula P, Ederra C, Urbiola A, España T, Venkatesan S, Balak DM, Karas P, Bolcková T, Streitová M, Carthel C, Coraluppi S, Harder N, Rohr K, Magnusson KE, Jaldén J, Blau HM, Dzyubachyk O, Křížek P, Hagen GM, Pastor-Escuredo D, Jimenez-Carretero D, Ledesma-Carbayo MJ, Muñoz-Barrutia A, Meijering E, Kozubek M, Ortiz-de-Solorzano C. A benchmark for comparison of cell tracking algorithms. Bioinformatics 2014; 30: 1609-17. Lugar: 4/52 Mathematical & Computational Biology. Primer decil. 
    ABSTRACT CORTESÍA DE PUBMED

  • Luis-Ravelo D, Antón I, Zandueta C, Valencia K, Ormazábal C, Martínez-Canarias S, Guruceaga E, Perurena N, Vicent S, De Las Rivas J, Lecanda F. A gene signature of bone metastatic colonization sensitizes for tumor-induced osteolysis and predicts survival in lung cancer. Oncogene. 2014; 33: 5090-9. IF: 8.559. Lugar: 12/203 Oncology. Primer decil. 
    ABSTRACT CORTESÍA DE PUBMED

  • Manterola L, Guruceaga E, Gállego Pérez-Larraya J, González-Huarriz M, Jauregui P, Tejada S, Diez-Valle R, Segura V, Samprón N, Barrena C, Ruiz I, Agirre A, Ayuso A, Rodríguez J, González A, Xipell E, Matheu A, López de Munain A, Tuñón T, Zazpe I, García-Foncillas J, Paris S, Delattre JY, Alonso MM. A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool. Neuro Oncol.2014; 16: 520-7. IF: 5.286. Lugar: 18/194 Clinical Neurology. Primer decil. 
    ABSTRACT CORTESÍA DE PUBMED



"We try to determine the mechanisms that promote carcinogenesis and metastasis of solid tumors with the goal of identifying and validating new molecular markers and therapeutic targets" , Dr. Rubén Pío, Program Director.

Contact

Contact:
Marisol Ripa
Avda. Pío XII, 55
31008 Pamplona
Spain

(+34) 948 194 700 Ext. 1010
msripa@unav.es